On 27 February 2026, CartaNova presented NovaID at the Tokyo AMR One-Health Conference, a regional forum under the Asia-Pacific AMR initiative (ASPPIRE) that convenes government and public health leaders across the Western Pacific and South-East Asia to strengthen regional coordination on antimicrobial resistance (AMR).

The presentation introduced NovaID as an AI-based clinical decision support and surveillance platform supporting antimicrobial stewardship, infection prevention and control, and microbiology capacity, including potential use cases for geographically dispersed and island settings.

CartaNova was also reportedly the first private-sector company invited to present at this government-led forum.

Please see details in the following minutes:

English: https://www.mhlw.go.jp/content/10900000/001690567.pdf
Japanese: https://www.mhlw.go.jp/content/10900000/001690568.pdf